Pune, May 31, 2022 (GLOBE NEWSWIRE) -- Cancer is a disease in which some of the body's cells grow uncontrollably and spread to other parts of the body. It is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018. Between 30% and 50% of cancer deaths could be prevented by modifying or avoiding key risk factors and implementing existing evidence-based prevention strategies. Early diagnosis improves cancer outcomes by providing care at the earliest possible stage and is therefore an important public health strategy in all settings. According to latest analysis by researcher, the global cancer diagnostics market is poised to grow by USD 75 billion during 2022-2028, progressing at a CAGR of 6.2% during the forecast period.
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats
Company Information: List of Top Manufacturers/ Key Players In Cancer Diagnostics Market Insights Report Are:
- Abbott Laboratories
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- GE Healthcare
- Hologic, Inc.
- Illumina, Inc.
- Koninklijke Philips N.V.
- Merck & Co., Inc.
- Qiagen N.V.
- Siemens Healthineers AG
- Thermo Fisher Scientific, Inc.
Get a sample copy of the Cancer Diagnostics market report 2022
On the thought of the product, this report displays the assembly, revenue, price, Classifications market share and rate of growth of each type, primarily split into
- laboratory tests
- genetic tests
- imaging
- endoscopy
- biopsy
- others
On the thought of the highest users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and rate of growth for each application, including
- hospitals and clinics
- diagnostic laboratories
- diagnostic imaging centres
- others
Get a Sample PDF of report @ https://proficientmarketinsights.com/enquiry/request-sample/20828726
This report focuses on the Cancer Diagnostics in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. The Cancer Diagnostics market report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The worldwide market for Cancer Diagnostics is anticipated to rise at a considerable rate during the forecast period, between 2021 and 2028. According to a new study.
The report can help to know the market and strategize for business expansion accordingly. Within the strategy analysis, it gives insights from market positioning and marketing channel to potential growth strategies, providing in-depth analysis for brand fresh entrants or exists competitors within the Cancer Diagnostics industry. Global Cancer Diagnostics Market Report 2022 provides exclusive statistics, data, information, trends and competitive landscape details during this niche sector.
Key questions answered in Cancer Diagnostics market report:
- What will the market growth rate of Cancer Diagnostics market in 2022?
- What are the key factors driving the global Cancer Diagnostics market?
- Who are the key manufacturers in Cancer Diagnostics market space?
- What are the market opportunities, market risk and market overview of the Cancer Diagnostics market?
- What are sales, revenue, and price analysis of top manufacturers of Cancer Diagnostics market?
- Who are the distributors, traders and dealers of Cancer Diagnostics market?
- What are the Cancer Diagnostics market opportunities and threats faced by the vendors in the global Cancer Diagnostics market?
- What are sales, revenue, and price analysis by types and applications of Cancer Diagnostics market?
- What are sales, revenue, and price analysis by regions of Cancer Diagnostics market?
With tables and figures helping analyse worldwide Global Cancer Diagnostics Market Forecast this research provides key statistics on the state of the industry and should be a valuable source of guidance and direction for companies and individuals interested in the market.
Inquire more and share questions if any before the purchase on this report at – https://proficientmarketinsights.com/enquiry/pre-order-enquiry/20828726
Table of Contents:
PART 1. INTRODUCTION
· Report description
· Objectives of the study
· Market segment
· Years considered for the report
· Currency
· Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
· Introduction
· Drivers
· Restraints
· Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY TYPE
· Laboratory tests
· Genetic tests
· Imaging
· Endoscopy
· Biopsy
· Others
PART 6. MARKET BREAKDOWN BY DISEASE INDICATION
· Blood cancer
· Breast cancer
· Cervical cancer
· Colorectal cancer
· Kidney cancer
· Liver cancer
· Lung cancer
· Ovarian cancer
· Pancreatic cancer
· Prostate cancer
· Skin cancer
· Others
PART 7. MARKET BREAKDOWN BY END USER
· Hospitals and clinics
· Diagnostic laboratories
· Diagnostic imaging centers
· Others
PART 8. MARKET BREAKDOWN BY REGION
· North America
· Asia Pacific
· Europe
· Rest of the World (ROW)
PART 9. KEY COMPANIES
· Abbott Laboratories
· Becton, Dickinson and Company
· Bio-Rad Laboratories, Inc.
· F. Hoffmann-La Roche AG
· GE Healthcare
· Hologic, Inc.
· Illumina, Inc.
· Koninklijke Philips N.V.
· Merck & Co., Inc.
· Qiagen N.V.
· Siemens Healthineers AG
· Thermo Fisher Scientific, Inc.
Reasons to buy this report:
- To get a comprehensive overview of the Cancer Diagnostics Market
- To gain wide ranging information about the top players in this industry, their product portfolios, and key strategies adopted by the players.
- To gain insights of the countries/regions in the Cancer Diagnostics Market.
Purchase this report (Price USD 2600 for a Single-User License): https://proficientmarketinsights.com/purchase/20828726
